XML 35 R24.htm IDEA: XBRL DOCUMENT
v3.23.1

Supplemental Balance Sheet Information (Tables) | 6 Months Ended
--- | ---
Mar. 31, 2023
Balance Sheet Related Disclosures [Abstract] |
Components of Inventories | Inventories consisted of the following components:
| March 31, |  |  | September 30, |
(In thousands) | 2023 |  |  | 2022 |
Raw materials | $ | 8,262 |  |  | $ | 6,102 |
Work-in process |  | 2,083 |  |  |  | 1,595 |
Finished products |  | 3,422 |  |  |  | 4,122 |
Total | $ | 13,767 |  |  | $ | 11,819 |
Summary of Prepaids and Other Current Assets | Prepaids and other current assets consisted of the following:
| March 31, |  |  | September 30, |
(In thousands) | 2023 |  |  | 2022 |
Prepaid expenses | $ | 4,034 |  |  | $ | 2,570 |
Irish research and development credits receivable |  | 836 |  |  |  | 753 |
CARES Act employee retention credit receivable (1) |  | 3,441 |  |  |  | 3,441 |
Prepaids and other | $ | 8,311 |  |  | $ | 6,764 |
(1) Receivable consisted of anticipated reimbursement of personnel expenses incurred in fiscal periods prior to fiscal 2023 as a result of our eligibility for the employee retention credit under the provisions of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”).
Schedule of Intangible Assets | Intangible assets consisted of the following:
| March 31, 2023 |
(Dollars in thousands) | Weighted Average Original Life (Years) |  |  | Gross Carrying Amount |  |  | Accumulated Amortization |  |  | Net |
Definite-lived intangible assets: |  |  |  |  |  |  |  |  |  |  |
Customer lists and relationships |  | 8.9 |  |  | $ | 12,476 |  |  | $ | (10,160 | ) |  | $ | 2,316 |
Developed technology |  | 11.9 |  |  |  | 34,708 |  |  |  | (9,883 | ) |  |  | 24,825 |
Patents and other |  | 14.1 |  |  |  | 3,551 |  |  |  | (2,546 | ) |  |  | 1,005 |
Total definite-lived intangible assets |  |  |  |  | 50,735 |  |  |  | (22,589 | ) |  |  | 28,146 |
Unamortized intangible assets: |  |  |  |  |  |  |  |  |  |  |
Trademarks and trade names |  |  |  |  | 580 |  |  |  | — |  |  |  | 580 |
Total intangible assets |  |  |  | $ | 51,315 |  |  | $ | (22,589 | ) |  | $ | 28,726 |
| September 30, 2022 |
(Dollars in thousands) | Weighted Average Original Life (Years) |  |  | Gross Carrying Amount |  |  | Accumulated Amortization |  |  | Net |
Definite-lived intangible assets: |  |  |  |  |  |  |  |  |  |  |
Customer lists and relationships |  | 8.9 |  |  | $ | 11,354 |  |  | $ | (8,827 | ) |  | $ | 2,527 |
Developed technology |  | 11.9 |  |  |  | 31,943 |  |  |  | (7,994 | ) |  |  | 23,949 |
Patents and other |  | 14.1 |  |  |  | 3,551 |  |  |  | (2,462 | ) |  |  | 1,089 |
Total definite-lived intangible assets |  |  |  |  | 46,848 |  |  |  | (19,283 | ) |  |  | 27,565 |
Unamortized intangible assets: |  |  |  |  |  |  |  |  |  |  |
Trademarks and trade names |  |  |  |  | 580 |  |  |  | — |  |  |  | 580 |
Total intangible assets |  |  |  | $ | 47,428 |  |  | $ | (19,283 | ) |  | $ | 28,145 |
Estimated Amortization Expense | Based on the intangible assets in service as of March 31, 2023, estimated amortization expense for future fiscal years was as follows:
(In thousands) |  |
Remainder of 2023 | $ | 1,888 |
2024 |  | 3,777 |
2025 |  | 3,741 |
2026 |  | 2,844 |
2027 |  | 2,593 |
2028 |  | 2,582 |
Thereafter |  | 10,721 |
Definite-lived intangible assets | $ | 28,146 |
Schedule of Carrying Amount of Goodwill By Reportable Segment | Changes in the carrying amount of goodwill by segment were as follows:
(In thousands) | In Vitro Diagnostics |  |  | Medical Device |  |  | Total |
Goodwill as of September 30, 2022 | $ | 8,010 |  |  | $ | 32,700 |  |  | $ | 40,710 |
Currency translation adjustment |  | — |  |  |  | 3,113 |  |  |  | 3,113 |
Goodwill as of March 31, 2023 | $ | 8,010 |  |  | $ | 35,813 |  |  | $ | 43,823 |
Summary of Other Noncurrent Assets | Other noncurrent assets consisted of the following:
| March 31, |  |  | September 30, |
(In thousands) | 2023 |  |  | 2022 |
Operating lease right-of-use assets | $ | 3,319 |  |  | $ | 3,633 |
Other |  | 1,437 |  |  |  | 1,136 |
Other assets | $ | 4,756 |  |  | $ | 4,769 |
Schedule of Accrued Other Liabilities | Accrued other liabilities consisted of the following:
| March 31, |  |  | September 30, |
(In thousands) | 2023 |  |  | 2022 |
Accrued professional fees | $ | 413 |  |  | $ | 279 |
Accrued clinical study expense |  | 1,896 |  |  |  | 1,425 |
Accrued purchases |  | 1,297 |  |  |  | 1,655 |
Acquisition of in-process research and development (1) |  | 967 |  |  |  | 981 |
Income tax payable |  | 36 |  |  |  | — |
Restructuring (2) |  | 308 |  |  |  | — |
Operating lease liability, current portion |  | 1,044 |  |  |  | 963 |
Other |  | 502 |  |  |  | 551 |
Total accrued other liabilities | $ | 6,463 |  |  | $ | 5,854 |
(1) Acquisition of in-process research and development consisted of the present value of guaranteed payments to be made (current portion) in connection with an asset acquisition in fiscal 2018 (Note 11). (2) Restructuring consisted of accrued severance and related expenses associated with a workforce restructuring initiated in the second quarter of fiscal 2023 (Note 12).
Schedule of Other Long-term Liabilities | Other long-term liabilities consisted of the following:
| March 31, |  |  | September 30, |
(In thousands) | 2023 |  |  | 2022 |
Deferred consideration (1) | $ | 3,404 |  |  | $ | 4,260 |
Contingent consideration (2) |  | 835 |  |  |  | 829 |
Unrecognized tax benefits (3) |  | 1,997 |  |  |  | 1,841 |
Operating lease liabilities (4) |  | 3,317 |  |  |  | 3,843 |
Other |  | 189 |  |  |  | — |
Other long-term liabilities | $ | 9,742 |  |  | $ | 10,773 |
(1) Deferred consideration consisted of the present value of guaranteed payments to be made (noncurrent portion) in connection with the fiscal 2021 Vetex acquisition and with an asset acquisition in fiscal 2018 (Note 11). (2) Contingent consideration consisted of the fair value of contingent consideration liabilities associated with the fiscal 2021 Vetex acquisition (Note 11). (3) Balance of unrecognized tax benefits (Note 10) includes accrued interest and penalties, if applicable. (4) Operating lease liabilities consisted of the non-current portion of the net present value of future minimum lease payments, reduced by the discounted value of leasehold improvement incentives paid or payable to the Company.

X
- Definition Schedule of accrued other liabilities. + References No definition available. + Details
Name: | srdx_ScheduleOfAccruedOtherLiabilitiesTableTextBlock
Namespace Prefix: | srdx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs. + References No definition available. + Details
Name: | us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of other noncurrent liabilities. + References No definition available. + Details
Name: | us-gaap_OtherNoncurrentLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1A -URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 55 -Paragraph 24 -URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(c)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(b)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766 + Details
Name: | us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of noncurrent assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration